Blog
RSS FeedPosted by Michael Wonder on 10 May 2021
Smart Immune announces FDA orphan drug status, IND acceptance and fast track designation to commence Phase 1/2 clinical trial of proprietary allogeneic T cell progenitor product SMART 101 (ProTcell) for AML and ALL
10 May 2021 - Phase 1/2 trial to begin by fall 2021 at a top US cancer centre. ...
Posted by Michael Wonder on 10 May 2021
Amgen announces tezepelumab biologics license application submitted to U.S. FDA
10 May 2021 - Potential first in class medicine blocking TSLP, an epithelial sytokine. ...
Posted by Michael Wonder on 10 May 2021
Positive CHMP opinion for self-administered Crysvita
10 May 2021 - The EMA's CHMP has recommended Kyowa Kirin’s Crysvita for a new self-administration option to treat the ...
Posted by Michael Wonder on 10 May 2021
China NMPA approves PARP inhibitor pamiparib for patients with previously treated advanced ovarian cancer
7 May 2021 - This marks the first approval of pamiparib and the third BeiGene discovered medicine to receive regulatory approval. ...
Posted by Michael Wonder on 09 May 2021
‘In their own bubble’: How a cancer center promoted an exclusive experimental drug to attract patients
6 May 2021 - A new medication for children with a rare and life-threatening cancer called neuroblastoma had a curious ...
Posted by Michael Wonder on 09 May 2021
Protest calls for more drug spending
9 May 2021 - Patients’ rights advocates will lie down on the job, as part of a nationwide day of ...
Posted by Michael Wonder on 09 May 2021
Families plead for PBS listing for ‘life-saving’ cystic fibrosis drug
8 May 2021 - A new drug is being hailed as a “game-changer” for cystic fibrosis sufferers as the government is ...
Posted by Michael Wonder on 08 May 2021
UK medicines regulator issues its first authorisation under Project Orbis
7 May 2021 - UK medicines regulator issues its first authorisation under Project Orbis for osimertinib (Tagrisso), a post-surgery treatment for ...
Posted by Michael Wonder on 07 May 2021
Medicare beneficiaries can't wait for lower drug prices
7 May 2021 - Medicare beneficiaries have been among the hardest-hit populations by the pandemic for the last 13 months — ...
Posted by Michael Wonder on 07 May 2021
High Council for Health calls for reimbursement for ADHD medication
5 May 2021 - The High Council for Health has issued a formal opinion calling for medication used in the treatment ...
Posted by Michael Wonder on 07 May 2021
Rather than turning its back on the QALY, pharma should collaborate on efforts to improve it
7 May 2021 - A key element in the long-simmering debate on reining in drug prices in the United States ...
Posted by Michael Wonder on 07 May 2021
The National Audit Office's review can contribute to strengthening TLV's work
7 May 2021 - On 6 May, the National Audit Office published its report on the Government's and TLV's work ...
Posted by Michael Wonder on 07 May 2021
EMA starts rolling review of sotrovimab (VIR-7831) for COVID-19
7 May 2021 - EMA’s CHMP has started a ‘rolling review’ of data on sotrovimab (also known as VIR-7831 and ...
Posted by Michael Wonder on 07 May 2021
Updated agenda for the July 2021 PBAC meeting
7 May 2021 - The agenda for the July 2021 PBAC meeting has been updated. ...
Posted by Michael Wonder on 06 May 2021
ICER to assess treatment for severe asthma
6 May 2021 - Report will be subject of Midwest CEPAC meeting in November 2021; draft scoping document open to ...